Developments in the field of antidepressants, where do we go now? / Francesc Artigas en European Neuropsychopharmacology, Año 2015 - Vol. 25 - No. 5 (Mayo)

Público ISBD [artículo]  inEuropean Neuropsychopharmacology > Año 2015 - Vol. 25 - No. 5 (Mayo) . - pp. 657-670 Título : Developments in the field of antidepressants, where do we go now? Tipo de documento: texto impreso Autores: Francesc Artigas, Autor Fecha de publicación: 2021 Artículo en la página: pp. 657-670 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Receptores de 5-hidroxitriptamina (serotonina), Medicamentos antidepresivos, Neurotransmisión glutamatérgica, Depresión mayor, Noradrenalina, Inhibición de la recaptación Resumen: Major depression is a severe psychiatric syndrome with very high prevalence and socio-economic impact. Its pathophysiology is poorly known, yet several neurotransmitter systems and brain areas have been implicated. Link: ./index.php?lvl=notice_display&id=26434 [artículo] Developments in the field of antidepressants, where do we go now? [texto impreso] / Francesc Artigas, Autor . - 2021 . - pp. 657-670. Idioma : Inglés (eng) Idioma original : Inglés (eng) in European Neuropsychopharmacology > Año 2015 - Vol. 25 - No. 5 (Mayo) . - pp. 657-670 Palabras clave: Receptores de 5-hidroxitriptamina (serotonina), Medicamentos antidepresivos, Neurotransmisión glutamatérgica, Depresión mayor, Noradrenalina, Inhibición de la recaptación Resumen: Major depression is a severe psychiatric syndrome with very high prevalence and socio-economic impact. Its pathophysiology is poorly known, yet several neurotransmitter systems and brain areas have been implicated. Link: ./index.php?lvl=notice_display&id=26434

Increased 5-hydroxytryptamine-2 receptor binding in the frontal cortex of depressed patients responding to paroxetine treatment: a positron emission tomography scan study / Raffaella Zanardi en Journal of Clinical Psychopharmacology, Año 2001 - Vol. 21 - No. 1 (Febrero)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 1 (Febrero) . - pp. 53-58 Título : Increased 5-hydroxytryptamine-2 receptor binding in the frontal cortex of depressed patients responding to paroxetine treatment: a positron emission tomography scan study Tipo de documento: texto impreso Autores: Raffaella Zanardi, Autor ; Francesc Artigas, Autor ; Rosamaria Moresco, Autor Fecha de publicación: 2023 Artículo en la página: pp. 53-58 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Depresión, Paroxetina, Corteza prefrontal, Receptores, Serotonina. Resumen: The changes in aminergic receptors elicited by antidepressant treatments have been extensively examined in the brain of experimental animals using radioligand and molecular techniques. However, there is a very limited direct information regarding the changes effected by such treatments in the human brain, as well as its relationship to clinical improvement. Link: ./index.php?lvl=notice_display&id=31137 [artículo] Increased 5-hydroxytryptamine-2 receptor binding in the frontal cortex of depressed patients responding to paroxetine treatment: a positron emission tomography scan study [texto impreso] / Raffaella Zanardi, Autor ; Francesc Artigas, Autor ; Rosamaria Moresco, Autor . - 2023 . - pp. 53-58. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 1 (Febrero) . - pp. 53-58 Palabras clave: Depresión, Paroxetina, Corteza prefrontal, Receptores, Serotonina. Resumen: The changes in aminergic receptors elicited by antidepressant treatments have been extensively examined in the brain of experimental animals using radioligand and molecular techniques. However, there is a very limited direct information regarding the changes effected by such treatments in the human brain, as well as its relationship to clinical improvement. Link: ./index.php?lvl=notice_display&id=31137

Reduced striatal dopamine DA D2 receptor function in dominant-negative GSK-3 transgenic mice / Raquel Gómez Sintes en European Neuropsychopharmacology, Año 2014 - Vol. 24 - No.9 (Septiembre)

Público ISBD [artículo]  inEuropean Neuropsychopharmacology > Año 2014 - Vol. 24 - No.9 (Septiembre) . - pp. 1524-1533 Título : Reduced striatal dopamine DA D2 receptor function in dominant-negative GSK-3 transgenic mice Tipo de documento: texto impreso Autores: Raquel Gómez Sintes, Autor ; Analia Bortolozzi, Autor ; Francesc Artigas, Autor Fecha de publicación: 2021 Artículo en la página: pp. 1524-1533 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Ganglios basales, Receptores de dopamina, Estriado dorsal, Glucógeno sintasa quinasa-3 (GSK-3), Esquizofrenia Resumen: Glycogen synthase kinase-3 (GSK-3) is a serine/threonine kinase with constitutive activity involved in cellular architecture, gene expression, cell proliferation, fate decision and apoptosis, among others. GSK-3 expression is particularly high in brain where it may be involved in neurological and psychiatric disorders such as Alzheimer׳s disease, bipolar disorder and major depression. Link: ./index.php?lvl=notice_display&id=26926 [artículo] Reduced striatal dopamine DA D2 receptor function in dominant-negative GSK-3 transgenic mice [texto impreso] / Raquel Gómez Sintes, Autor ; Analia Bortolozzi, Autor ; Francesc Artigas, Autor . - 2021 . - pp. 1524-1533. Idioma : Inglés (eng) Idioma original : Inglés (eng) in European Neuropsychopharmacology > Año 2014 - Vol. 24 - No.9 (Septiembre) . - pp. 1524-1533 Palabras clave: Ganglios basales, Receptores de dopamina, Estriado dorsal, Glucógeno sintasa quinasa-3 (GSK-3), Esquizofrenia Resumen: Glycogen synthase kinase-3 (GSK-3) is a serine/threonine kinase with constitutive activity involved in cellular architecture, gene expression, cell proliferation, fate decision and apoptosis, among others. GSK-3 expression is particularly high in brain where it may be involved in neurological and psychiatric disorders such as Alzheimer׳s disease, bipolar disorder and major depression. Link: ./index.php?lvl=notice_display&id=26926

---

1 (1 - 3 / 3)